Asthma is the most common chronic respiratory disease in children, affecting approximately 14% of children globally and accounting for significant school absences and emergency healthcare use. Inhaled corticosteroids are the foundation of preventive therapy; stepwise management guided by control assessment drives escalation decisions. Biologic therapies approved in adult severe asthma are progressively extending to paediatric age groups.
Loading articles...
